Narcotic dosage and central nervous system opiate receptor binding

Area of Science:

• Pharmacology
• Neuroscience

Background:

• Lofentanil is a potent, long-acting narcotic analgesic.
• Understanding the dose-response relationship of narcotics is crucial for safe and effective clinical use.

Purpose of the Study:

• To investigate the relationship between lofentanil dosage, analgesia, anesthesia, and central nervous system (CNS) opiate-receptor occupancy in rats.
• To determine the lofentanil dose required for complete opiate receptor saturation.

Main Methods:

• Intravenous administration of increasing lofentanil doses (0-10.0 micrograms/kg) to rats.
• Assessment of analgesia via tail withdrawal reflex inhibition.
• Evaluation of anesthesia by response to bone-crush injury.
• Measurement of CNS opiate-receptor occupancy using [3H] sufentanil binding inhibition.

Main Results:

• Increasing lofentanil doses led to dose-dependent increases in analgesia and anesthesia.
• Analgesia was observed at doses where opiate receptor binding was below measurable levels.
• Anesthesia occurred at approximately 25% opiate receptor occupancy in specific brain regions.
• Complete opiate receptor saturation in rats required a dose eight times the anesthetic dose.

Conclusions:

• In rats, significant lofentanil doses are required to achieve complete central nervous system (CNS) opiate receptor saturation.
• The clinical significance of complete opiate receptor saturation during narcotic anesthesia requires further investigation.